Stephens Inc’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,890
Closed -$284K 1316
2024
Q4
$284K Buy
7,890
+238
+3% +$8.05K ﹤0.01% 1041
2024
Q3
$325K Sell
7,652
-299
-4% -$12.7K ﹤0.01% 996
2024
Q2
$320K Sell
7,951
-405
-5% -$16.9K ﹤0.01% 980
2024
Q1
$296K Buy
8,356
+8,028
+2,448% +$215K ﹤0.01% 1008
2023
Q4
$9.7K Sell
328
-1,746
-84% -$36.2K ﹤0.01% 1239
2023
Q3
$43.1K Sell
2,074
-57
-3% -$1.56K ﹤0.01% 1151
2023
Q2
$52.3K Buy
2,131
+11
+0.5% +$354 ﹤0.01% 1163
2023
Q1
$86.1K Buy
2,120
+317
+18% +$13.1K ﹤0.01% 1100
2022
Q4
$81K Sell
1,803
-250
-12% -$11.3K ﹤0.01% 1081
2022
Q3
$98K Buy
2,053
+772
+60% +$42.3K ﹤0.01% 1103
2022
Q2
$76K Buy
1,281
+350
+38% +$28.7K ﹤0.01% 1143
2022
Q1
$108K Buy
931
+690
+286% +$80.6K ﹤0.01% 1221
2021
Q4
$36K Hold
241
﹤0.01% 1299
2021
Q3
$29K Buy
241
+174
+260% +$19.2K ﹤0.01% 1319
2021
Q2
$7K Sell
67
-16
-19% -$1.43K ﹤0.01% 1336
2021
Q1
$7K Sell
83
-17
-17% -$1.58K ﹤0.01% 1300
2020
Q4
$10K Buy
+100
New +$10.3K ﹤0.01% 1209
2019
Q4
Sell
-1,750
Closed -$103K 1197
2019
Q3
$103K Hold
1,750
﹤0.01% 1099
2019
Q2
$113K Buy
+1,750
New +$113K ﹤0.01% 1130

Other funds holding TNDM

Stephens Inc's TNDM Position: Q1 2025 in Review

Stephens Inc sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 7,890 shares — an estimated $284K sold.

Stephens Inc first reported a position in TNDM in Q2 2019 and held it in 19 quarters. The position peaked at $325K in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Stephens Inc reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Stephens Inc sold 7,890 Tandem Diabetes Care shares in Q1 2025, an estimated $284K.
  • Stephens Inc first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 19 quarters.
  • Stephens Inc's Tandem Diabetes Care position peaked at $325K in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Stephens Inc's 13F filing for Q1 2025, filed 1 May 2025.